Image of people smiling and meeting around a table. "KOL engagement".
Meet your strategic congress objectives with KOL engagement services scalable to your needs, and ensure your data generation planning and key messaging reflect insights from top KOLs, and allied HCPs.
🔴🧠
info@rednucleus.com | rednucleus.com/contact-us #medcomms
Image of a glomerulus of the kidneys from our animation team. "See you at #AUA24".
Attending #AUA24? We are! Meet our team in San Antonio—let's discuss how we can enhance your Medical Communications and Learning & Development strategies.
Not at the conference? Reach us via info@rednucleus.com or rednucleus.com/contact-us/?...
.
🔴🧠
#urology #medcomms #MedAffairs
Image of the poster over an image of DNA.
Come visit RN MACS at ISPOR in Atlanta! We are presenting a poster on the effects of Accelerated Approval (AA) on Access and Coverage Outcomes.
Questions? Want a copy of the poster? Contact sshan@rednucleus.com or via
rednucleus.com/contact-us?u...
.
🔴🧠
#ISPOR2024 #MarketAccess
Images of certificate, and team discussing in front of the poster.
🎈 Congrats to our team at #ISMPPAnnual2024! "Most Visionary Research Award" for our poster abstract USE OF GENERATIVE AI IN MEDICAL COMMUNICATIONS FOR SUMMARIZATION TASKS.
Get your copy of our poster:
info@rednucleus.com or
rednucleus.com/contact-us?u...
🧠🔴
#AI #medcomms
"Meet us at #Asembia24" - Red Nucleus logo. 3d medical animation created in-house: dark image of teal and bright red, blood cells moving through a vessel with a web of filaments around in teal.
Meet the Red Nucleus Market Access & Commercialization team at #ASEMBIA2024 in Las Vegas! Stay ahead of the evolving dynamics in the pricing and reimbursement ecosystem to achieve market success.
🔴 Apr 28—May 2
🔴 Booth 1917
🟣 info@rednucleus.com
🔵 rednucleus.com/contact-us/?...
#AXS24 #LifeSciences
The Red Nucleus team is not only well versed in the rules and regulations in Japan, but we understand the expectations and business culture of the Japanese authorities and how to best engage them.
info@rednucleus.com or rednucleus.com/contact-us/?... .
🔴🧠
#WODC2024 #ASEMBIA2024
Image of the downloadable slide on a textured background.
To encourage the early launch of new drugs in Japan, Chuikyo introduced a “rapid launch premium" to take effect starting this month.
Download our PDF for insights on how this will affect your pricing strategies from LinkedIn: www.linkedin.com/feed/update/...
#pharmasky
Red and blue vesicles from a 3D animation our team created, with "Meet Red Nucleus at the World Orphan Drug Congress" and "#WODC2024"
Join us at #WODC2024 in Boston! Are you interested in how to maximize the value and impact of patient centered evidence? Start leveraging our integrated approaches from trials to access—reach out to us today at info@rednucleus.com or via rednucleus.com/contact-us/?...
"Poster Presentation #ISMPPAnnual2024" Image of poster and title as described.
Attending #ISMPPAnnual2024? Don't miss our poster, “Use of generative artificial intelligence (AI) in medical communications for summarization tasks”, presented by Danielle Shepherd, PhD.
🔴🧠
Request a copy: rednucleus.com/contact-us?u...
#genAI #medcomms
In this poster we will explore:
🔴Launch list prices and list price differentials between markets for top high-revenue drugs between 2020-23
🟣Price differentials between markets by therapeutic area, orphan drug status, biologics vs. non-biologics
🔵Potential rationales for price differentials
Image of "Price Differentials by Therapeutic Area" poster with DNA model behind it.
Visit the Red Nucleus MACS team at ISPOR in Atlanta! We are presenting a poster on trends in launch prices across US, Canada, EU4 and UK for high-revenue drugs.
10:30 AM – 1:30 PM, May 7, 2024
Poster Session 3, poster code EE276
#ISPOR2024 #MarketAccess
Our support services can include:
🟣 Guiding KOL identification;
🟣 Outreach & scheduling;
🟣 Developing discussion guides and talking points;
🟣 Creation of post-meeting summaries;
🟣 Quickly identifying action items and key takeaways;
and more.
Image of people smiling and meeting around a table. "KOL engagement".
Meet your strategic congress objectives with KOL engagement services scalable to your needs, and ensure your data generation planning and key messaging reflect insights from top KOLs, and allied HCPs.
🔴🧠
info@rednucleus.com | rednucleus.com/contact-us #medcomms
"See you at #CMO360". Image of glowing cell next to another apoptosis cell. Teal frame.
Are you ready for #CMO360? We are! Meet our team in Boston this week—we look forward to discussing the value of video outcome measures in combating pitfalls associated with outcomes sensitivity.
🔴🧠
info@rednucleus.com |
rednucleus.com/contact-us?u...
#ClinicalTrials
"Meet Red Nucleus at #AMCP2024" Image in deep blues of apoptosis occurring, from our animation team.
Join our team at the AMCP Annual Meeting in New Orleans! Let's connect and discuss how our Market Access & Commercialization (MACS) team can help you achieve market success.
We hope to see you there, April 15-18.
Connect via info@rednucleus.com or
rednucleus.com/contact-us/?...
🔴🧠
#AMCP2024
🟣 What is the relationship between US prevalence and launch price, and how do other product attributes affect price?
🔵 What is the impact of being first-in-indication and/or a first-in-class product on US launch price?
#ISPOR2024
We will explore:
🔴 What are the common attributes of orphan drugs and how have these attributes evolved over time?
#ISPOR2024
Example of one of the posters about orphan drug launch price characteristics.
Come visit the Red Nucleus MACS team at #ISPOR2024 in Atlanta! We are presenting 3 posters leveraging proprietary data from our 2015-22 US non-oncology orphan drug database.
💊
For your poster copy, contact Dan Krieger dkrieger@rednucleus.com or via: rednucleus.com/contact-us/?...
Photo of the glossy Apple Vision Pro XR headset under a Red Nucleus "RN" sign, out of focus in the background.
Our digital team is exploring the possibilities for medical education and training on the Apple Vision Pro. We’re excited to share our demo!
What are you excited to see on it?
🔴🧠
#MedComms #LandD #XR
Image from 3d medical animation of neurons in beige and blue, with blue border. "See you at #AAN2024".
Meet the Red Nucleus team at #AAN2024 in Denver. We're excited to share our visions for the future of Medical Communications and Learning & Development with you.
Not at the meeting? Let's start the conversation: info@rednucleus.com or rednucleus.com/contact-us.
🔴🧠
#AAN
Title of session and logos for Race In Stem and Red Nucleus. Background frame of DNA pattern in periwinkle and reds on pale grey.
Don't miss "Promoting Diversity, Equity, and Inclusion in the Global Age of Medical Communications”, a roundtable discussion at this year’s ISMPP meeting.
Hosted by Red Nucleus & Race In STEM, April 29, 3:30pm EST.
🔴🧠
#ISMPPAnnual2024 #DEI #medcomms
whova.com/web/FV-MQBAv...
Announcement with photo of Willem.
We're happy to announce Willem Heydendael has joined Red Nucleus as Senior Director of Business Development. With 10+ years of experience developing & executing business and scientific strategies, we're excited he's on our team.
Welcome Willem!
🔴🧠
www.linkedin.com/feed/update/...
Image of people in an office, with swooping RN red lines. "Selling higher, Broader, and Deeper" "Essential Skills Workshop".
Based on industry-leading market research, SELLING HIGHER, BROADER AND DEEPER prepares individuals for greater selling success through developing a set of crucial skills.
Launch your team to the next level with this Essential Skills workshop.
🔴🧠
rednucleus.com/rnti/selling...
"Meet Red Nucleus at #AACR2024" "April 6-10, San Diego" Image of a dark background, and a watery-surfaced cell undergoing cystic growth in oily purples. From an animation test of ours.
Attending #AACR2024? We hope you'll connect with the Red Nucleus team while you're there. We're excited to share our visions for the future of MedComms and L&D with you.
Not at the meeting? Reach out to our team at info@rednucleus.com or
tinyurl.com/rn-convo, and let's start the conversation.
In this poster we will explore:
🔴How payers have approached management of novel gene therapies
🟣How payer restrictions have impacted uptake of gene therapies
🔵Which payers implement the most restrictive management
Hope to see you at #ISPOR2024!
Graph showing Payer Management of Gene Therapies.
Come visit RN’s Market Access and Commercialization team at ISPOR in Atlanta!
We are presenting a poster on the US Gene Therapy Access Landscape.
If you can't wait for ISPOR, contact us today:
rednucleus.com/contact-us/?...
🔴🧠
#genetics #ISPOR2024
Image of DNA sequence in glowing colours. "Let's talk about strategic and tactical publications at #ISMPPAnnual2024. Meet the Red Nucleus team. #ISMPPAnnual2024 | April 29, 2024"
If you’d like to hear more about our strategic and tactical publications offerings, please schedule some time to meet with us at the upcoming #ISMPP meeting in Washington D.C.
We'd love to chat with you over dinner!
Or contact us: rednucleus.com/contact-us/?...
Image of Gregory, and title the same as above. DNA readout abstracted image in the frame.
If you’re attending #ISMPPAnnual2024 this year, don’t forget to register for the “Introduction to Publication Planning: The Best of the Basics” workshop on Monday, April 29th, led by our VP of Scientific Services & Strategy, Gregory Bezkorovainy.
🔴🧠
tinyurl.com/rn-ismpp-GB
Welcome message and image of Marie Faber. "Welcome Marie Faber Senior Director of Business Development to Red Nucleus" Date at bottom March 28, 2024
We're excited to announce the newest addition to our team, Marie Faber, who has joined Red Nucleus as Senior Director of Business Development. With 17+ years of experience, Marie brings a wealth of knowledge and industry expertise.
Welcome, Marie!
🔴🧠
www.linkedin.com/feed/update/...
